Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Silence Therapeutics plc
DescriptionShort interfering RNA (siRNA) lipoplex against angiopoietin 2 (ANG2; ANGPT2)
Molecular Target Angiopoietin 2 (ANG2) (ANGPT2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today